Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | November 1, 2005 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00334594 |
| Study Type: | Interventional |
| Intervention: | Drug: cisplatin|Drug: pemetrexed disodium|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Procedure: quality-of-life assessment|Radiation: radiation therapy |
| Study Design: | Allocation: Randomized|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Swiss Group for Clinical Cancer Research |
| Ages: | Adult|Senior |
| Enrollment: | 155 |
| Funded By: | Other |
| First Received: | June 7, 2006 |
| End Date: | |
| Last Updated: | October 30, 2009 |
| Last Verified: | July 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
